AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15519779
Drug: Oral sucralfate
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sucralfate (3 g suspension, twice daily)
Trial: 29893790
Drug: Palbociclib monotherapy
RxNorm normalized name: Palbociclib
DrugBank: Palbociclib (DB09073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Palbociclib monotherapy
Trial: 19298023
Drug: Cobalt-chrome (CC)
RxNorm normalized name: Cobalt
DrugBank: Cobalt (DB14574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobalt-chrome (CC) femoral heads
Trial: 6258959
Drug: Terbutaline sulphate
RxNorm normalized name: Terbutaline sulphate
DrugBank: Terbutaline (DB00871)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terbutaline sulphate aerosol (1.0‐1.25 mg)
Trial: 14968327
Drug: Tacalcitol emulsion
RxNorm normalized name: tacalcitol
DrugBank: Tacalcitol (DB13689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacalcitol emulsion (4 micro g/g) once daily
Trial: 22110105
Drug: Potassium excretion
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium excretion 2.5-3 g/day
Trial: 18030180
Drug: Counting pill
RxNorm normalized name: oteseconazole
DrugBank: Oteseconazole (DB13055)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Counting pill intake
Trial: 15197051
Drug: Echinacea purpurea
RxNorm normalized name: Echinacea purpurea
DrugBank: Echinacea purpurea (DB14239)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea purpurea (100 mg, freeze-dried pressed juice from the aerial portion of the plant) 3 times daily until symptoms relieved or 14 days
Trial: 11479480
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with ticlopidine (TIC) and ASA, n = 16
Trial: 2264175
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) vaginal tablets
Trial: 8452189
Drug: 7-day ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 7-day ciprofloxacin (250 mg twice a day)
Trial: 26201426
Drug: Pharmaceutical intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical intervention
Trial: 7564921
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4.0 g/day)
Trial: 7564921
Drug: Safflower oil
RxNorm normalized name: Safflower Oil
DrugBank: Safflower oil (DB09446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safflower oil (4.0 g/day)
Trial: 31898518
Drug: Fasting Diet
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting Diet (FD) with a 7-day fast every 6 months and 14-hour daily intermittent fasting
Trial: 30165520
Drug: Unchanged LT4
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Unchanged LT4 dose
Trial: 31718254
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 70 mg/day
Trial: 22248761
Drug: NSAIDs and
RxNorm normalized name: methenamine
DrugBank: Methenamine (DB06799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NSAIDs and intravenous morphine
Trial: 3064527
Drug: Consecutive plasmapheresis
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Consecutive plasmapheresis (plasma exchanges every 2 to 3 days during a period of 2 to 3 weeks) with continuation of oral immunosuppressive therapy
Trial: 3064527
Drug: Chronic intermittent
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic intermittent treatment (once per week) with parallel immunosuppression
Trial: 7789055
Drug: Natural estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Natural estradiol (0.05 mg/day) for 6 months
Trial: 7082023
Drug: Heat administered
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heat administered before or after UV exposure
Trial: 14984381
Drug: Interferon-alpha plus
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha plus amantadine (200 mg/day)
Trial: 22918704
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy (gel) for 6 months
Trial: 8439642
Drug: Calcium polycarbophil
RxNorm normalized name: Calcium Polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium polycarbophil (6 g/day)
Trial: 20551634
Drug: Intravaginal pentamycin
RxNorm normalized name: Benzamycin
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal pentamycin 100 mg
Trial: 31324081
Drug: Vildagliptin-Metformin
RxNorm normalized name: vildagliptin
DrugBank: Vildagliptin (DB04876)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Vildagliptin-Metformin
Trial: 23023529
Drug: 2RT laser
RxNorm normalized name: aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2RT laser therapy
Trial: 8339412
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 1200 mg bamiphylline
Trial: 20920045
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro protamine suspension (ILPS)
Trial: 21835316
Drug: Initial medical
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial medical therapy with deferred revascularization
Trial: 28212390
Drug: Olive Oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive Oil (OO) control (3 g/d)
Trial: 12440337
Drug: Arilin rapid
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arilin rapid x 1 glob./2 days followed by vaginal tablets containing lactic acid x 1 glob. for 7 days
Trial: 12913401
Drug: Early eptifibatide
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early eptifibatide administration (in the Emergency Department, n = 27)
Trial: 31242517
Drug: PD1 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PD1 inhibitor pembrolizumab
Trial: 1768559
Drug: Prochlorperazine (PCZ)
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (PCZ) 12.5 mg i.v.
Trial: 1768559
Drug: Prochlorperazine (PCZ)
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (PCZ) 50 mg oral
Trial: 27523814
Drug: Compound clotrimazole
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Compound clotrimazole cream (Control)
Trial: 24960254
Drug: L-DOPA
RxNorm normalized name: L-dopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: L-DOPA
Trial: 8797468
Drug: Acetyl-L-carnitine hydrochloride
RxNorm normalized name: Acetyl-L-carnitine hydrochloride
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine hydrochloride (ALCAR) 3 g/day
Trial: 26659366
Drug: Capecitabine 2000
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 2000 mg/m² day 1-14 (ARM A)
Trial: 26659366
Drug: Capecitabine 2000
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 2000 mg/m² day 1-14 + mitomycin C 6 mg/m² day 1 (ARM B)
Trial: 20545388
Drug: Levodopa with
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa with CM-MEDICATION condition
Trial: 9071515
Drug: Levonorgestrel rod
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel rod (LNG ROD) implants
Trial: 8164924
Drug: NORPLANT implants
RxNorm normalized name: Norplant 3-oxime
DrugBank: Norelgestromin (DB06713)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NORPLANT implants
Trial: 7637045
Drug: 3-drug solution
RxNorm normalized name: goserelin
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-drug solution (papaverine + phentolamine + prostaglandin E1)
Trial: 8737615
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol
Trial: 10928154
Drug: Complementary immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary immunotherapy with galactoside‐specific lectin from mistletoe (ML‐1)
Trial: 22420596
Drug: Allopurinol augmentation
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol augmentation (caffeine abstainers)
Trial: 6575576
Drug: PGE2 tablets
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PGE2 tablets (Prostin)
Trial: 7492458
Drug: 1 litre
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 litre of beverage containing 50 g alcohol
Trial: 1652611
Drug: Dronabinol and
RxNorm normalized name: Dronabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dronabinol and prochlorperazine, each 10 mg every 6 hr
Trial: 27435048
Drug: Alternating chemoradiotherapy
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating chemoradiotherapy (ACRT) consisting of two cycles of chemotherapy (5‐fluorouracil and cisplatin) and radiotherapy; administered alternately over weeks 1-7
Trial: 1861552
Drug: Adjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant hormonal therapy
Trial: 9183308
Drug: d-Fenfluramine 15
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Fenfluramine 15 mg twice daily for 12 weeks
Trial: 24150779
Drug: BG-12 240
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 240 mg twice daily (BID)
Trial: 15151838
Drug: V+D+M treatment
RxNorm normalized name: M-End Max D
DrugBank: Pseudoephedrine (DB00852)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: V+D+M treatment protocol (levofloxacin, pasiniazide, M. Vaccae)
Trial: 25015027
Drug: MPH-LA 40
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPH-LA 40 mg/day
Trial: 9097275
Drug: Interferon-alpha treatment
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha treatment for 12 months (Group II)
Trial: 15595937
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate (GA) therapy
Trial: 11777488
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (ORTHO EVRA/EVRA)
Trial: 26872112
Drug: Olanzapine plus
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine plus metformin
Trial: 23328380
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (G, F, G+F)
Trial: 11832363
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) injections (n=7)
Trial: 18931006
Drug: Galantamine hydrobromide
RxNorm normalized name: Galantamine Hydrobromide
DrugBank: Galantamine (DB00674)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Galantamine hydrobromide ER (8 mg/day for 4 weeks, 16 mg/day for 6 weeks, 24 mg/day for 6 weeks)
Trial: 25253884
Drug: Previous GFJ-drug
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Previous GFJ-drug interaction studies
Trial: 7498689
Drug: Polyethylene glycol-based
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol-based electrolyte lavage solution (administered the day before colonoscopy)
Trial: 31167892
Drug: Insulin Glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin Glargine (INS)
Trial: 26133944
Drug: triamcinolone injection
RxNorm normalized name: triamcinolone Injection
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: triamcinolone injection
Trial: 16672093
Drug: 1 ng
RxNorm normalized name: NG
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ng mL(‐1) remifentanil (n = 24)
Trial: 16672093
Drug: 3 ng
RxNorm normalized name: NG
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ng mL(‐1) remifentanil (n = 22)
Trial: 16005154
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl (INF)
Trial: 9001831
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg BID
Trial: 21601481
Drug: Target Hb
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Target Hb value in normal range (130‐149 g/l), group 2, n=46
Trial: 11771747
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (5 mg patch)
Trial: 4736626
Drug: Stilboestrol 1
RxNorm normalized name: Stilboestrol
DrugBank: Diethylstilbestrol (DB00255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stilboestrol 1 mg daily
Trial: 30922373
Drug: ABP 501
RxNorm normalized name: ABPC
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ABP 501 (40 mg every other week for 68 weeks)
Trial: 3520389
Drug: Intensified insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified insulin therapy with three daily doses of MC rapid insulin, two of which associated with MC intermediate insulin
Trial: 22432105
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy initiated in 855 patients
Trial: 24648482
Drug: Intraperitoneal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal lidocaine administration (IP)
Trial: 24648482
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine infusion (IV)
Trial: 4014870
Drug: Intermittent heavy
RxNorm normalized name: heavy mineral oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent heavy exercise (VE, 68 L/min) lasting 14 min every 30 min during exposure
Trial: 9527747
Drug: Low-dose opioid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose opioid anaesthesia (thoracic epidural analgesia combined with inhalational anaesthesia)
Trial: 1461782
Drug: Vaccine containing
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine containing the strains Edmonston‐Zagreb, Rubini and Wistar Ra 27/3
Trial: 3528718
Drug: Postoperative human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative human albumin administration
Trial: 20561115
Drug: Individually tailored
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually tailored oral health educational programme (ITOHEP)
Trial: 3925430
Drug: Both vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vaccines (C(OAc‐) and C(OAc+))
Trial: 9226738
Drug: Self-administration behavior
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administration behavior
Trial: 8062954
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) and hMG
Trial: 29529919
Drug: Kinect-based VR
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Kinect-based VR training + Physical Therapy (PT)
Trial: 26866933
Drug: Transanal submucosal
RxNorm normalized name: mepivacaine
DrugBank: Mepivacaine (DB00961)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transanal submucosal injection of polyacrylamide hydrogel
Trial: 23642377
Drug: Ranibizumab (monthly)
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab (monthly)
Trial: 28973227
Drug: Early resuscitation
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early resuscitation protocol for sepsis (n=107) including intravenous fluid bolus administration, vasopressors targeting mean arterial pressure (≥65 mm Hg), and blood transfusion for hemoglobin <7 g/dL.
Trial: 9669827
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 250 microg twice daily via the Diskhaler (DH)
Trial: 27434314
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate once-monthly (PP1M) injectable
Trial: 26400458
Drug: Vercirnon 500
RxNorm normalized name: Vercirnon
DrugBank: Vercirnon (DB15250)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vercirnon 500 mg once daily
Trial: 12629090
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist triptorelin (GnRHa) plus calcium supplementation
Trial: 12629090
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist triptorelin (GnRHa)
Trial: 22978595
Drug: Turmeric rhizome
RxNorm normalized name: Turmeric Rhizome (Curcuma Longa)
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turmeric rhizome powder (TRP) 0 g/kg (Control)
Trial: 27743396
Drug: Crestal implants
RxNorm normalized name: Crystal ammonia
DrugBank: Ammonium carbonate (DB15926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crestal implants placed at bone level
Trial: 24295556
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 250 μg BD
Trial: 31299774
Drug: Ridge-split technique
RxNorm normalized name: BLUE RIDGE BLUEBERRY
DrugBank: Blueberry (DB10629)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ridge-split technique with horizontal augmentation using autogenous bone graft
Trial: 31299774
Drug: Ridge-split method
RxNorm normalized name: BLUE RIDGE BLUEBERRY
DrugBank: Blueberry (DB10629)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ridge-split method with simultaneous implant placement
Trial: 20023215
Drug: Sequential rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sequential rituximab (375 mg/m2) after completion of all chemotherapy
Trial: 3019375
Drug: Cilazapril 10
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 10 mg
Trial: 17370498
Drug: Seeds of
RxNorm normalized name: Plantago Seed
DrugBank: Plantago seed (DB11097)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seeds of Brassica Alb (0.01 g each point)
Trial: 28051798
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) monotherapy